KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Current Liabilities (2016 - 2025)

AbbVie (ABBV) has disclosed Total Current Liabilities for 14 consecutive years, with $43.3 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 11.72% to $43.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.3 billion through Dec 2025, up 11.72% year-over-year, with the annual reading at $43.3 billion for FY2025, 11.72% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $43.3 billion at AbbVie, up from $39.4 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $43.3 billion in Q4 2025, with the low at $27.6 billion in Q1 2023.
  • Average Total Current Liabilities over 5 years is $35.5 billion, with a median of $35.0 billion recorded in 2021.
  • The sharpest move saw Total Current Liabilities surged 93.98% in 2021, then decreased 16.07% in 2022.
  • Over 5 years, Total Current Liabilities stood at $35.2 billion in 2021, then fell by 16.07% to $29.5 billion in 2022, then grew by 28.11% to $37.8 billion in 2023, then rose by 2.4% to $38.7 billion in 2024, then rose by 11.72% to $43.3 billion in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $43.3 billion, $39.4 billion, and $39.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.